Answers are grounded in this paper and cite their sources.
To the Editor—Staphylococcus aureus bacteremia (SAB) remains a morbid and often mortal infection. The recent article by López-Cortés et al [1] demonstrated a reduction in mortality when a bundle of interventions were used in conjunction with evidence-based standards of care for SAB management. We recently reviewed our experience with the influence of infectious diseases consultations on SAB management and outcomes, and our results reinforce many of the interventions advocated by López-Cortés, as well as those of previous studies demonstrating the benefit of infectious diseases consultation in the management of SAB [2–9]. We systematically reviewed all 191 SABs at our medical center during 2011 to evaluate whether infectious diseases consultation affected crude mortality. We also recorded the type and duration of antibiotic, whether follow-up blood cultures and echocardiography were performed, whether a focal source was present, and whether the focal source, if present, was removed. Fourteen of 191 bacteremic patients were excluded from our analysis because they died or were discharged or transferred within 48 hours after the diagnosis of SAB. Statistical analyses were performed with SPSS software and Microsoft Excel software, with continuous and nominal data evaluated with the Student t test and the χ2 test, respectively.
No takes yet. Share an insight, caveat, or question.
Fries et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: